Business
Currency:JPY
2024/FY
Stock NameRevenueRatio
Gastroenterology1.22T28.52%
Plasma Derived Therapies (PDT) Immunology818.57B19.20%
Neuroscience627.01B14.71%
Rare Genetics and Other465.4B10.92%
Oncology462.36B10.84%
Other368.91B8.65%
Rare Hematology305.3B7.16%
View all
Region
Currency:JPY
2024/FY
Stock NameRevenueRatio
United States (US)2.2T51.50%
Europe and Canada966.84B22.68%
Japan451.39B10.59%
Asia (Excluding Japan)261.22B6.13%
Latin America198.1B4.65%
Other117.91B2.77%
Russia/Commonwealth of Independent States (CIS)72.59B1.70%
View all
